Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06406309 · ClinicalTrials.gov registry record · NA

Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD

A NA study of Attention Deficit Hyperactivity Disorder and Sleep Disturbance, sponsored by University of Pittsburgh.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06406309: Active NA study of Attention Deficit Hyperactivity Disorder and Sleep Disturbance, sponsored by University of Pittsburgh.

NCT06406309 is a NA study of Attention Deficit Hyperactivity Disorder and Sleep Disturbance that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 30 participants, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06406309, a NA study of Attention Deficit Hyperactivity Disorder and Sleep Disturbance, is active but no longer recruiting, sponsored by University of Pittsburgh.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is test the hypothesis that sleep problems for children with ADHD are linked to sensory over-responsivity, a type of sensory processing difference that causes a person to interpret daily sensory input as stressful. This study examines the impact of sensory over-responsivity on bedtime arousal levels in 30 children with ADHD (ages 6-13). We will also test a bedtime intervention targeting sensory over-responsivity at bedtime and examine how it impacts bedtime arousal levels and sleep difficulties.

Primary Outcome

Caregiver-reported Sensory Profile-2 questionnaire: Sensitivity sub scale score (score range of 0 - 95, with higher numbers indicating more frequent endorsement)

Conditions Studied

Attention Deficit Hyperactivity Disorder Sleep Disturbance

Interventions

  • BEHAVIORAL Power Down manipulation

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-11-01
Est. Completion 2026-07
Phase NA
University of Pittsburgh

1,238 total trials

What the registry record for NCT06406309 still lists

NCT06406309 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 216-participant average among 102 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (86% lower).

The record links to 2 conditions, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 1 intervention - of which Power Down manipulation is the first listed.

NCT06406309 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06406309 about?

NCT06406309 is a clinical study titled "Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD". The goal of this study is test the hypothesis that sleep problems for children with ADHD are linked to sensory over-responsivity, a type of sensory processing difference that causes a person to interpret daily sensory input as stressful. This study examines the impact of sensory over-responsivity on...

What is the current status of trial NCT06406309?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-11-01. Estimated completion is 2026-07.

What conditions does trial NCT06406309 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder, Sleep Disturbance.

What interventions are being tested in trial NCT06406309?

The interventions under investigation include: Power Down manipulation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06406309?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06406309 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06406309's enrollment target sits among peer trials

30 81st of 102 higher than 14 of 102 other Attention Deficit Hyperactivity Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Attention Deficit Hyperactivity Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT06406309, the US trial registry maintained by the National Library of Medicine. NCT06406309 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.